The FAA is moving to allow pilots with type 1 diabetes to take command of U.S.-based commercial flights, reports CNN.
The device, similar to the G6 on the market, is intended for use by clinicians that want their patients to test out the device.
Two U.K. case-based studies found evidence that use of the devices helped uncover bouts of low blood sugar among frail, elderly patients.
New research affirms the importance of CGM use in blood sugar management. We discuss the value of CGMs with Dr. Tomas Walker, the Senior Medical Director for Dexcom.
The Envision Pro will be factory-calibrated, disposable, and is intended for use by health care professionals.
Senseonics continues to make inroads in its rollout of the Eversense CGM.
An overview of insulin pump therapy, with Diabetes Care and Education Specialist Ashlee Ernst.
How the founder of Integrated Medical Sensors was motivated to develop better blood sugar monitoring options by his mother’s diabetes diagnosis.
Dexcom officials shared this news and more details about its pipeline of diabetes technology in a recent earnings call.
Presenters, including members of the T1D Exchange Quality Improvement Collaborative, discussed ways to raise awareness of the upside of CGM use among the patient population.
Already a Member?
This pioneering effort provides a mobile-friendly platform for people throughout the U.S. to participate online and share information about their type 1 diabetes